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Two-dimensional and Doppler echocardiography were 
performed in 17 consecutive hospitalized patients with 
cystic fibrosis aged 6 to 38 years (mean 21 ± 9) and in 
10 normal subjects aged 24 ± 7 years. Left ventricular 
and right ventricular ejection fraction were measured 
by a computljl"ized light pen system and Simpson's rule 
from two-dimensional echocardiographic apical four and 
two chamber views. Right ventricular wall thickness, 
inferior vena cava size and the presence of tricuspid 
regurgitation by Doppler recording were also assessed. 
National Institutes of Health (NIH) score of clinical se-
verity ranged from 22 to 72 (mean SI ± IS) (100 = 
excellent, 0 = poor). Four patients, all with an NIH 
score of 40 or less, died of respiratory failure within 1 
year of the echocardiographic study. 
There was no significant difference between patients 
Cystic fibrosis is a congenital disorder of unknown etiology 
affecting primarily the exocrine glands and involving mul-
tiple organs including the lungs and the pancreas (I). Car-
diac involvement in these patients is considered to be sec-
ondary to chronic progressive pulmonary disease and usually 
presents as cor pulmonale with or without right-sided heart 
failure (2). On the basis of autopsy observations and hemo-
dynamic data, chronic cor pulmonale is expected to be pres-
ent in the majority of patients dying of cystic fibrosis (1,3). 
Previous echocardiographic studies (4-6) found increased 
right ventricular wall thickness and dimensions and abnor-
mal systolic time intervals in these patients. 
In this study we examined the effects of cystic fibrosis 
on right and left ventricular systolic function using quan-
titative two-dimensional echocardiography; the presence of 
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with cystic fibrosis and normal subjects with regard to 
right ventricular ejection fraction (S9 ± 11 versus 61 ± 
10%), left ventricular ejection fraction (67 ± 8 versus 
70 ± 8%) and right ventricular systolic (S ± 1 versus 
S ± O.S mm) and diastolic (2.4 ± O.S versus 2.S ± O.S 
mm) wall thicknesses. A dilated inferior vena cava and 
mild tricuspid regurgitation by Doppler recording were 
detected in only one patient. A poor correlation was 
found between right ventricular ejection fraction and 
NIH clinical score (r = 0.26), chest X-ray score (r = 
0.29) and pulmonary function tests. It is concluded that 
right and left ventricular systolic function is preserved 
in patients with moderately severe cystic fibrosis; clinical 
status in these patients is probably determined by the 
pulmonary rather than cardiac involvement. 
(J Am Coli CardioI1985;6:701-6) 
tricuspid regurgitation in these patients was assessed by 
combined Doppler echocardiographic examination. 
Methods 
Patients. The study included 17 consecutive patients with 
cystic fibrosis who were admitted to Hahnemann University 
Hospital with acute exacerbation of their chronic lung dis-
ease; the 10 men and 7 women were aged 21 ± 9 years 
(mean ± SD) (range 6 to 38). The diagnosis of cystic 
fibrosis was established at least I year before this admission 
by a positive sweat test, typical clinical history and the 
presence of chronic lung disease with or without pancreatic 
insufficiency. The control group consisted of 10 subjects 
concurrently studied who were aged 24 ± 7 years (mean 
± SD) and had no cardiac or lung disease by history, 
physical examination and echocardiographic evaluation. 
All patients with cystic fibrosis had a chest roentgeno-
gram, pulmonary function tests and complete two-dimen-
sional and Doppler echocardiographic examination within 
48 hours of admission. Clinical severity was determined 
using the Shwachman-Kulczycki scoring system (7). In this 
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system, a sUbjective score of up to 25 points is assigned for 
general activity, nutrition, physical examination and chest 
X-ray results. A clinical score of 86 to 100 implies excellent 
condition, a score of 71 to 85 good condition, a score of 
56 to 70 mild disease, a score of 41 to 55 moderate disease 
and a score of 40 or less severe disease. In addition, the 
National Institutes of Health (NIH) score, which includes 
pulmonary function tests, was determined (8). Pulmonary 
function tests included forced vital capacity, forced expi-
ratory volume in I second and maximal mid-expiratory flow 
rate expressed as percent of predicted normal for age, height 
and sex. Chest roentgenograms were evaluated using the 
Brasfield scoring system (9). 
Echocardiography. Two-dimensional echocardio-
graphic studies were preformed using the Advanced Tech-
nology Laboratories ADR-4000SC mechanical sector scan-
ner and a 3.0 MHz, 13 mm focus transducer. All standard 
parasternal, apical and subcostal views were used. M-mode 
and Doppler echocardiographic studies were performed uti-
lizing the IREX III System and a 2.5 MHz transducer. 
Derived M -mode echocardiographic measurements of right 
ventricular wall thickness in end-systole and end-diastole 
were attempted in all patients utilizing the parasternal or 
subcostal views (10). Three separate measurements of the 
view providing optimal imaging of the right ventricular wall 
were obtained and averaged. The inferior vena cava was 
evaluated by placing the transducer in a subxiphoid or right 
subcostal position. The M-mode cursor was used to generate 
a time-motion recording of the inferior vena cava through 
several respiratory cycles. An end-diastolic diameter of 
7 ± 3 mrnlm2 with a 50% or more decrease during inspi-
ration was considered normal (11). 
Right ventricular ejection fraction by two-dimensional 
echocardiography was determined utilizing the biplane 
Simpson's rule and a computerized light pen system (Dia-
sonics Cardio ReVue Center). Two paired echocardio-
graphic views assumed to be approximately perpendicular 
to each other were used for the calculation of right ventric-
ular ejection fraction: the apical four chamber and the apical 
right ventricular two chamber views (12). Similarly, left 
ventricular ejection fraction was determined by the apical 
four and two chamber views, utilizing the Simpson's rule 
and the same light pen system. Images were manually traced 
by outlining the endocardial edge at end-diastole (onset of 
QRS complex or largest cavity) and end-systole (end of T 
wave or smallest cavity) and the tracings were saved on the 
data disc for calculation of volumes. 
The presence and severity of tricuspid regurgitation by 
Doppler echocardiography were assessed utilizing the pulsed 
mode Doppler technique and the right ventricular inflow-
outflow view or the apical four chamber view. The presence 
of a well defined, holosystolic jet on spectral display was 
considered indicative of tricuspid regurgitation. It was quan-
tified by mapping of the regurgitant flow in the right atrium 
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(13) and was considered mild when the high intensity re-
gurgitant jet was recorded just below the tricuspid valve, 
moderate when recorded in the proximal right atrium and 
severe when recorded in the distal right atrium. 
Statistical analysis. All measurements in the text and 
table are expressed as mean ± SO. Comparison between 
the measurements of patients and normal subjects was per-
formed using the Student's t test. Correlation between the 
echocardiographic right ventricular ejection fraction and 
clinical score, chest X-ray score and pulmonary function 
tests was performed by linear regression analysis. A prob-
ability value of 0.05 or less was considered statistically 
significant. 
Results 
Clinical data (Table 1). The Shwachman-Kulczycki 
clinical score ranged from 24 to 78 (mean 55 ± 14) and 
the NIH clinical score ranged from 22 to 72 (mean 51 ± 
15). Only 4 of the 17 patients had severe disease (NIH score 
:::;40) and clinical signs (facial and peripheral edema that 
responded to diuretic drugs) suggestive of right heart failure. 
The remaining patients had either moderate disease (clinical 
score 41 to 55) or mild disease (clinical score 56 to 70). 
All patients were discharged from the hospital in improved 
condition. All four patients with an NIH score of 40 or less 
subsequently died of progressive respiratory failure within 
1 year of the echocardiographic study. Autopsy in two pa-
tients revealed a heart weight of 390 g in both and a right 
ventricular wall thickness of 8 and 7 mm, respectively. The 
coronary arteries were normal. 
Echocardiographic data (Table 1). M-mode echocar-
diographic measurement of right ventricular wall thickness 
was possible in II (65%) of 17 patients. The right ventric-
ular systolic wall thickness was 5 ± I mm in patients with 
cystic fibrosis and 5 ± 0.5 mm in normal subjects (p = 
NS); the diastolic wall thickness was 2.4 ± 0.5 mm in 
patients with cystic fibrosis and 2.5 ± 0.5 mm in normal 
subjects (p = NS). Doppler examination was normal in all 
patients except one in whom mild tricuspid regurgitation 
was detected. In the same patient, the inferior vena cava 
was dilated. All the remaining patients had a normal-sized 
inferior vena cava with a normal respiratory variation by 
M-mode echocardiogram. 
Regional or diffuse wall motion abnormalities of the right 
or left ventricle were not detected by subjective evaluation 
of two-dimensional echocardiograms. Only two patients 
demonstrated mildly abnormal ventricular septal motion. 
The apical four and two chamber views of the left and right 
ventricles for the quantitative estimation of ejection fraction 
were obtained in 15 (88%) of 17 patients; in 2 patients, this 
estimation was obtained using a single plane subcostal view. 
The right ventricular ejection fraction in patients with cystic 
fibrosis was 59 ± 11 % (range 44 to 74%), not statistically 
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Echocardiographic Data 
Age (yr) 
Clinical Score Pulmonary Function Tests RV Thickness (mm) 
& X-ray 
Case Sex S/K NIH Score FYC(%) FEV,(%) MMEFR(%) Syst Diast RYEF(%) LVEF(%) 
1* 22M 24 28 5 42 20 4 7 3 44 56 
2* 11M 51 40 13 43 26 5 65 72 
3* 27M 31 22 8 32 19 5 71 74 
4 20F 39 41 12 46 32 12 46 59 
5 IBM 63 62 14 68 65 43 55 54 
6 23M 58 50 13 64 38 13 5 2 48 67 
7 7F 60 57 15 56 30 7 5 2 49 60 
8 22F 67 72 16 71 66 43 6 3 74 70 
9 27M 78 71 18 68 54 22 4 :; 73 53 
to 15M 66 65 16 80 74 45 5 2 51 63 
II 28M 48 46 12 49 26 6 4 2 70 68 
12 38M 66 59 13 32 25 9 6 3 53 71 
13 13F 61 65 14 99 87 42 3 2 69 70 
14 29F 60 52 12 49 43 21 65 78 
15 6F 56 62 17 64 60 20 70 72 
16* 25F 42 35 II 29 22 7 4 2 60 75 
17 34M 57 46 to 48 22 5 6 3 45 78 
Mean 21 55 51 13 56 42 18 5 2.4 59 67 
±SD ±9 ± 14 ± 15 ±3 ± 19 ±21 ± 15 ±I ±0.5 ±II ±8 
*Died within I year of the echocardiographic study. Diast = diastole; F = female; FEY, = forced expiratory volume.in I second; FVC = forced 
vital capacity; L VEF = left ventricular ejection fraction; M = male; MMEFR = maximal mid-expiratory flow rate; NIH = National Institutes of 
Health; RY = right ventricular; RVEF = right ventricular ejection fraction; S/K = Shwachman-Kulczycki; Syst = systole. 
different from that in the normal group (61 ± 10%). Sim-
ilarl y , left ventricular ejection fraction in patients with cystic 
fibrosis was not statistically different from that of normal 
subjects (67 ± 8 versus 70 ± 8%) (Fig. 1). There was a 
poor correlation between the echocardiographic right ven-
tricular ejection fraction and the clinical score by the 
Shwachman-Kulczycki system (r = 0.19) or the NIH scor-
ing system (r = 0.24); the correlation between the echo-
cardiographic right ventricular ejection fraction and the chest 
Figure 1. Right ventricular (RVEF) and left ventricular (LVEF) 
ejection fraction determined by two-dimensional echocardiography 
in 17 patients with cystic fibrosis (CF) and in 10 normal subjects. 
There is no significant difference in the mean right and left ven-
tricular ejection fractions between these two groups. 
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X-ray score was also poor (r = 0.34) (Fig. 2). Comparison 
between the pulmonary function tests (including forced vital 
capacity and forced expiratory volume in 1 second) and the 
right ventricular ejection fraction also did not disclose any 
significant correlation (Fig. 3). 
Discussion 
Cor pulmonale in cystic fibrosis. Cor pulmonale has 
been defined (14) as hypertrophy of the right ventricle re-
sulting from diseases affecting the function or structure, or 
both, of the lung provided that these pulmonary alterations 
are not the result of congenital heart disease or diseases that 
Figure 2. A poor correlation is shown between the echocardio-
graphic (Echo) right ventricular ejection fraction (RVEF) and the 
NIH clinical score and the chest X-ray score in 17 patients with 
cystic fibrosis. 
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Figure 3. A poor correlation is shown between the echocardio-
graphic (Echo) right ventricular ejection fraction (RVEF) and the 
pUlmonary function tests including forced vital capacity (FVC) and 
forced expiratory volume in I second (FEV I) expressed as the 
percent of predicted normal value for age, height and sex. 
primarily affect the left side of the heart. This definition 
does not necessarily imply right-sided heart failure. The 
clinical recognition of cor pulmonale may be difficult, even 
in the presence of right-sided heart failure, because several 
signs and symptoms usually ascribed to heart failure may 
be manifestations of the underlying lung disease (I). M-
mode echocardiography is a reliable technique and is prob-
ably superior to electrocardiography and vectorcardiography 
in determining right ventricular hypertrophy (15,16). In-
creased right ventricular wall thickness and dimensions and 
abnormal right ventricular systolic time intervals have been 
reported (4-6) in patients with cystic fibrosis utilizing M-
mode echocardiography. A scoring system combining these 
echographic abnormalities was found to correlate well with 
the clinical and chest roentgenographic severity of this dis-
ease (17). However, the functional and clinical significance 
of these abnormalities in patients with cystic fibrosis and 
their effect on the right ventricular systolic wall motion in 
various stages of the disease have not been elucidated. 
Right ventricular function in cystic fibrosis. In con-
trast to previous investigators (4-6,17,18), we found no 
significant abnormalities of the right ventricular wall thick-
ness, dimension and systolic function by qualitative and 
quantitative analysis of two-dimensional echocardiograms 
in patients with various degrees of severity of lung disease 
and a clinical NIH score ranging from 22 to 72 (mean 
51 ± 15). Measurement of right ventricular wall thickness 
was not possible, however, in 35% of the patients including 
three patients with severe disease. The estimation of right 
ventricular ejection fraction by two-dimensional echocardi-
ography utilizing the apical four and two chamber right 
ventricular views has been previously validated in our lab-
oratory (12). The estimated right ventricular ejection frac-
tion in 10 normal subjects aged 24 ± 7 years was 61 ± 
10%, which is not significantly different from the value of 
53 ± 6% determined by first pass radionuclide angiography 
JACC Vol. 6. No.3 
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in normal young adults (19). The estimated echocardio-
graphic right ventricular ejection fraction in our patients with 
cystic fibrosis was 59 ± 11 % (p = NS versus normal 
subjects) (Fig. 1). The inferior vena cava size and its res-
piratory variation, which reliably reflect right ventricular 
function (11), were normal in all but one patient. In addition, 
we found a poor correlation between the echocardiographic 
right ventricular ejection fraction and the NIH score (r = 
0.24), chest X-ray score (r = 0.34) and pulmonary function 
tests (Fig. 2 and 3). 
Chipps et al. (18), utilizing radionuclide angiography, 
demonstrated an abnormal right ventricular ejection fraction 
in the majority of patients with cystic fibrosis. Matthay et 
al. (20), however, used the same technique and showed that 
the magnitude of right ventricular dysfunction is related to 
the severity of cystic fibrosis; an abnormal right ventricular 
ejection fraction was found only in patients with severe 
disease (Shwachman-KuJczycki clinical score 42 ± 4). 
This observation is confirmed by other investigators (21) 
utilizing two-dimensional echocardiography who showed 
marked right ventricular dilation and flattening or compres-
sion of the ventricular septum in the majority of patients 
with advanced lung disease and clinically manifested right-
sided heart failure. 
Our findings of normal systolic right ventricular function 
by echocardiography can be explained because the majority 
of our patients had only mild to moderate lung disease and 
only four had a clinical NIH score of 40 or less. The rel-
atively mild clinical severity, even though II (60%) of 17 
patients were older than 20 years of age (mean 21 ± 9) 
may reflect diagnostic and therapeutic advances in this dis-
ease. From our findings and those of others (20), it appears 
that systolic right ventricular function is maintained in the 
majority of patients with moderately severe cystic fibrosis 
and may be impaired only in the severe end-stage of the 
disease. Therefore, the clinical status and the morbidity and 
mortality of these patients are probably determined by the 
respiratory rather than the cardiac status. Even in the four 
patients who had severe disease (NIH score ::540), right 
ventricular systolic wall motion was preserved as assessed 
by two-dimensional echocardiography; all of these four pa-
tients died of respiratory failure within I year of the echo-
cardiographic study. 
Limitations. Accurate assessment of systolic right ven-
tricular function by two-dimensional echocardiography may 
be limited in patients with lung disease and technically sub-
optimal studies. it appears that the most severely ill patients 
in acute respiratory distress will have the least technically 
optimal studies and these are the patients in whom echo-
cardiographic data would be most useful. Furthermore, de-
termination of right ventricular ejection fraction by two-
dimensional echocardiography may not be very accurate 
because of the complex geometry of the right ventricle (12). 
On the other hand, many patients with cystic fibrosis may 
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succumb to pulmonary infection and respiratory insuffi-
ciency before they develop end-stage cor pulmonale, In 
addition, hemodynamic evidence exists (22) which indicates 
that right ventricular contractile function is usually pre-
served in young patients with congenital heart disease and 
chronic right ventricular pressure overload. Right ventric-
ular dilation and dysfunction, therefore, may develop only 
at the end-stage of the disease just before the patient's death. 
Left ventricular function in cystic fibrosis. Previous 
studies (23,24) have shown that in the presence of severe 
right ventricular pressure or volume overload, or both, but 
without right-sided heart failure, the left ventricular ejection 
fraction remains virtually normal. Left ventricular dysfunc-
tion in patients with cystic fibrosis may be caused by hy-
poxia, acidosis, myocardial fibrosis or an abnormal ven-
tricular septal motion due to compression from a markedly 
dilated right ventricle (1,21). Abnormal left ventricular 
function has been demonstrated in a small percent of patients 
with cystic fibrosis utilizing systolic time intervals (6) or 
first pass radionuclide angiography (18). Other studies (20), 
however, utilizing radionuclide techniques, found normal 
left ventricular function even when the lung disease was 
severe. We found a normal left ventricular ejection fraction 
by quantitative two-dimensional echocardiography in our 
study group. These observations suggest that left ventricular 
function is preserved in moderately severe cystic fibrosis 
and that it may not be abnormal even in the late stages of 
the disease. 
Tricuspid regurgitation in cystic fibrosis. A typical 
murmur of tricuspid regurgitation has been reported in a 
small percent of patients with cystic fibrosis and clinical 
heart failure (2). Doppler echocardiography is a very sen-
sitive technique for the detection of even mild degrees of 
tricuspid regurgitation which, however, can sometimes be 
found in normal subjects (25). Semiquantitation of the se-
verity of tricuspid regurgitation by the pulsed Doppler tech-
nique utilizing mapping of the regurgitant jet into the right 
atrium has been found to be clinically useful (13). The 
accuracy of this method, however, is difficult to establish, 
because an optimal standard for comparison is not available. 
In our study group, we detected mild tricuspid regurgitation 
associated with dilation of the inferior vena cava in only 1 
of the 17 patients. Because there is an association between 
the severity of pulmonary hypertension and the presence of 
tricuspid regurgitation (26), this finding suggests that sig-
nificant tricuspid regurgitation is not commonly present in 
cystic fibrosis and probably does not play an important role 
in the patient's clinical deterioration. 
Clinical implications. Our findings suggest that right 
and left ventricular systolic function as assessed by quan-
titative two-dimensional echocardiography are preserved in 
patients with moderately severe cystic fibrosis. Therefore, 
the clinical status of these patients is mainly determined by 
their respiratory rather than cardiac status, and appropriate 
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treatment should be addressed toward the improvement of 
pulmonary function. Cardiac involvement may be more im-
portant only in the advanced and severe stages of this disease. 
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